Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
In a Fish With Ataxia, Ions Can’t Surf Its Channels
11 May 2011. Spinocerebellar ataxias, a collection of movement diseases in which cerebellar neurons die, are closely linked with polyglutamine repeats and protein aggregation (Paulson, 2009). But that is not the whole story: Some ataxias, for example, spinocerebellar ataxia 13 (SCA13), are due to mutations in ion channels. Even in disease caused by polyglutamine expansion, there is some evidence that ion channels are not working properly, said Henry Paulson of the University of Michigan in Ann Arbor.

Now, researchers from the University of California, Los Angeles, show in a new zebrafish model for SCA13 how malfunction of the ion channel might contribute to disease. The paper appears in the May 4 Journal of Neuroscience. In humans, SCA13 is caused by dominant-negative mutations in one of the four identical subunits of the Kv3.3 potassium channel. Mutations in even one subunit render channels non-functional (see ARF related news story on Waters et al., 2006). The new study, led by first author Fadi Issa and senior author Diane Papazian, determined that the channel is expressed in primary motor neurons, among the earliest to develop in the embryonic spinal cord. The cerebellum develops later.

To mimic the disease, the scientists injected zebrafish embryos with RNA encoding the dysfunctional subunit containing an R420H mutation. This particular mutation causes late-onset ataxia in people with SCA13. Issa examined the effects of the mutation in embryos two or three days after fertilization.

The Kv3.3 channel normally drives persistent, high-frequency firing in motor neurons. With the mutant subunit interfering with the formation of the tetrameric channels, the firing rate dropped, and many of the caudal primary neurons the scientists examined were spent before the end of a 60-millisecond stimulation in patch-clamp experiments. “The fundamental issue is that each and every neuron seems to be firing less frequently, and that reduces their output,” said Pierre Drapeau of the University of Montréal, Canada, whose lab Issa visited for electrophysiology training. “Though we've known for several years that causative mutations occurred in the KCNC3 voltage-gated potassium channel, this is the first report demonstrating altered neuronal excitability in an animal model of disease,” wrote Michael Waters, University of Florida, Gainesville. (See full comment below.)

This faulty firing could lead to neurodegeneration in a variety of ways, Papazian said. For example, calcium enters the cells via voltage-dependent influx. A lifetime of gradually altered calcium levels could eventually damage a cell, she suggested. Calcium concentrations have also been fingered as potential mechanisms for neurodegeneration in Alzheimer’s disease (Supnet and Bezprozvanny, 2010).

Issa also looked for behavioral effects from the mutant channel. Morphologically speaking, the zebrafish embryos developed normally, but their early movement was altered. Issa used the well-known startle response (Korn and Faber, 2005), prodding the embryo’s tails with a pin so they will dart away. He kept the mutant RNA levels low so the response would still occur. Fish with unimpaired Kv3.3 function flip so that they face 180 degrees away from the stimulus and can swim in the opposite direction. But the fish with the mutant Kv3.3 turned at much more variable angles, averaging only 143 degrees away from the prod. “The startle response was no longer reliable in moving the animal directly away from the stimulus,” Papazian said. The response reminded her of people with SCA13, who tend to take small steps of variable length rather than walking with a regular stride (Palliyath et al., 1998).

Because the RNA treatment only lasted a few days, the researchers were unable to look for long-term effects in adult fish. Another caveat is that Issa’s fish are an embryonic, spinal cord model for an adult-onset, cerebellar disease. Papazian and colleagues are currently working to achieve longer-term expression, as well as on a rat model that may provide answers in adult animals. Most ataxias have been linked to potentially toxic protein aggregates, but the researchers did not examine for those in this fish model. Either way, the research confirms, to Paulson’s mind, that “we need to be thinking about channel dysfunction in human ataxias,” he told ARF. He further suggested that modulators of channel function might be effective treatments.—Amber Dance.

Reference:
Issa FA, Mazzochi C, Mock AF, Papazian DM. Spinocerebellar ataxia type 13 mutant potassium channel alters neuronal excitability and causes locomotor deficits in zebrafish. J Neurosci. 2011 May 4:31(18):6831-41. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Spinocerebellar ataxia type 13 mutant potassium channel alters neuronal excitability and causes locomotor deficits in zebrafish.

Comment by:  Michael Waters
Submitted 6 May 2011  |  Permalink Posted 6 May 2011

This exciting report by Issa et al. is a critical advance in beginning to understand the essential underlying pathophysiology of SCA13. Though we've known for several years that causative mutations occurred in the KCNC3 voltage-gated potassium channel, this is the first report demonstrating altered neuronal excitability in an animal model of disease. That this effect was characterized in a cell-specific manner and occurred in locomotor behavior provides compelling clues to human disease pathology. This important research begins to lay the groundwork from which we can move away from basic experimental systems and closer to animal physiology and behavior in an effort to understand the fundamental mechanisms of SCA13 in humans pursuant to effective treatments and potential cures.

View all comments by Michael Waters

  Primary Papers: Spinocerebellar ataxia type 13 mutant potassium channel alters neuronal excitability and causes locomotor deficits in zebrafish.

Comment by:  Philip Van Damme
Submitted 9 May 2011  |  Permalink Posted 9 May 2011

In this paper by Issa et al., the functional consequence of a mutation in the gene encoding a K-channel (Kv3.3), which is known to cause SCA13 in humans, was studied. SCA13 mutations are not associated with protein aggregation and therefore provide an opportunity to study the link between altered ion channel function and neurodegeneration in the absence of protein aggregation. In zebrafish embryos, in vivo patch-clamp studies revealed that the mutant K-channel suppressed the excitability of fast-firing motor neurons in the spinal cord. This correlated with the observed motor phenotype. The next challenge will be to understand how this neuronal dysfunction induces neurodegeneration and how it can be alleviated.

View all comments by Philip Van Damme
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad